Learning outcomes
By the end of this lesson you should be able to: distinguish antigenic drift from antigenic shift in influenza and explain why a new subtype produces a pandemic; describe the paramyxoviruses and the clinical signature of measles, mumps and respiratory syncytial virus; describe the arboviruses and flaviviruses and their vectors, and the clinical patterns of dengue, Japanese encephalitis and chikungunya; describe the enteroviruses, the two poliovirus vaccines and the elimination programme; describe retroviruses, the replication of HIV and the drug classes that target it; and name the clinical syndromes of norovirus, rotavirus, and the coronaviruses.
Prerequisites
Lessons 10 and 11. The Baltimore classification, the envelope and the notion of a segmented genome from general virology are the keys to this lesson.
The big idea
The RNA viruses are the most variable of human pathogens, because RNA-dependent RNA polymerases have no proof-reading, so they make an error with every replication round. That inaccuracy produces antigenic drift, permits escape from immunity and vaccination, and makes surveillance an annual exercise. Where the genome is segmented — influenza has eight RNA segments on its own — a second phenomenon adds: co-infection of a cell by two strains can shuffle the segments and produce a radically new virus.
The clinical consequence is a division of the RNA viruses into those we can control (the vaccine types, polio and measles) and those we cannot (the seasonal influenza types, the coronaviruses, and HIV). The dividing line is mutation rate, host range, and whether a single stable antigen can be targeted by long-lived antibody.
Orthomyxoviridae: influenza
| Type | Subtypes | Human disease | Key facts |
|---|---|---|---|
| Influenza A | Haemagglutinin H1–H16 with neuraminidase N1–N9; the human-adapted subtypes include H1N1 and H3N2 | Seasonal epidemics, and all four pandemics of the modern era | Reservoir in aquatic birds; co-infection of pigs can mix human, avian and swine segments; H5N1 and H7N9 are zoonotic |
| Influenza B | Victoria and Yamagata lineages | Seasonal epidemics in children and older adults | Only a human virus; contributes to disease each winter but does not cause pandemics |
| Influenza C | One subtype | Mild upper respiratory infection | Rarely diagnosed and not epidemic |
| Influenza D | Cattle reservoir | Not a human pathogen of note | Worth mentioning because it shows how host range constrains emergence |
Influenza A replication is a masterclass in anti-viral design. Haemagglutinin binds sialic acid and fuses the envelope to the endosomal membrane; neuraminidase cleaves sialic acid to release budding virions from the cell surface and to let the virus move through mucus; the trimeric polymerase, carried in the particle, transcribes the negative-sense segments; and the whole cycle is accelerated by the segment-8 gene that produces NS1, a protein that suppresses the interferon response.
| Drug | Target | Effect | Place |
|---|---|---|---|
| Oseltamivir (oral), zanamivir (inhaled) | Neuraminidase | Prevents release and spread | Treatment begun within 48 hours, and for prophylaxis in outbreaks |
| Baloxavir marboxil | Cap-dependent endonuclease of the polymerase | Halts transcription early in the cycle | A single oral dose, but mutation of the polymerase reduces susceptibility |
| Amantadine and rimantadine | The M2 ion channel | Prevents uncoating | Withdrawn from routine use because of widespread resistance |
NoteThe great influenza pandemic of 1918 was caused by an H1N1 virus of avian-like genome that killed an estimated 50 million people, with a mortality concentrated in young adults — plausibly because their immune systems had not seen any influenza A before and mounted an overwhelming cytokine response. It was not drift but the introduction of an entirely new subtype, and the 2009 pandemic was caused by a triple-reassortant H1N1 drawn from human, avian and swine segments.
Paramyxoviridae
| Virus | Disease | Signature clinical features | Vaccine and control |
|---|---|---|---|
| Measles virus | Measles — a highly contagious systemic illness | Fever, cough, coryza and conjunctivitis, then a maculopapular rash spreading cephalocaudally, with Koplik spots on the buccal mucosa; complications include pneumonia, and subacute sclerosing panencephalitis years later | Live attenuated measles-containing vaccine in two doses, given at 9 and 16 months in the national schedule, with a second dose to catch primary vaccine failures |
| Mumps virus | Mumps — painful parotitis | Parotid swelling with fever; complications include orchitis in post-pubertal boys, meningitis, pancreatitis and sensorineural deafness | Live attenuated vaccine in MMR |
| Respiratory syncytial virus (RSV) | Bronchiolitis in infants, pneumonia in the elderly | Wheezing and respiratory distress with copious secretions; diagnosed by antigen or nucleic acid test on a nasopharyngeal aspirate | Palivizumab monoclonal prophylaxis in high-risk infants; adult vaccines and maternal immunisation are now available |
| Parainfluenza viruses 1–4 | Croup, pharyngitis, bronchiolitis | The barking cough and steeple sign of laryngotracheobronchitis | No vaccine |
| Nipah and Hendra viruses | Zoonotic encephalitis, spread by fruit bats and pigs | Encephalitis with relapsing symptoms and very high mortality | No licensed human vaccine; control depends on avoiding fruit-bat and pig contact |
Watch outMeasles is not a mild rash: it transiently suppresses the whole immune system, including cellular recall responses, and leaves the child vulnerable to bacterial pneumonia and to measles-induced immune amnesia. That is why measles mortality in low-income settings is a childhood killer, and why vitamin A supplementation is standard, because the epithelium of the cornea and respiratory tract depend on it.
Arboviruses and flaviviruses
| Virus | Vector and reservoir | Disease | Clinical and diagnostic notes |
|---|---|---|---|
| Dengue virus (4 serotypes) | Aedes aegypti and Aedes albopictus, from infected humans; the principal reservoir in the city cycle | Classic dengue fever, dengue haemorrhagic fever, dengue shock syndrome | Severe disease is usually associated with secondary infection by a different serotype; NS1 antigen and IgM in the first week, RT-PCR for confirmation |
| Chikungunya (alphavirus) | Aedes mosquitoes | Sudden fever with severe symmetric polyarthralgia and a rash | Arthralgia may persist for months; distinguished from dengue by the intensity of joint pain and by serology or RT-PCR |
| Japanese encephalitis (flavivirus) | Culex mosquitoes, with pigs and wading birds as amplifying reservoirs | Encephalitis with seizures and a characteristic low-density thalamic lesion on imaging | A killed vaccine given to children in endemic districts; childhood vaccination has been the single most effective control |
| West Nile virus (flavivirus) | Culex mosquitoes, with birds as reservoir | Asymptomatic infection, West Nile fever, or neuroinvasive disease | A cause of flaccid paralysis and encephalitis in older adults |
| Zika virus (flavivirus) | Aedes mosquitoes, with human and primate reservoirs | Mild febrile illness, Guillain–Barré syndrome, and congenital Zika syndrome | Maternal infection causes microcephaly and fetal demise, so pregnancy advice on travel matters |
| Yellow fever (flavivirus) | Aedes and Haemagogus mosquitoes, with a monkey reservoir | Febrile illness with jaundice, haemorrhage and a high mortality | A live attenuated vaccine given to travellers and endemic populations; a vaccine certificate is required for entry to some countries |
| KFD and Alkhurma (tick-borne flaviviruses) | Ticks | Haemorrhagic fever | Regional in South Asia and the Arabian peninsula; managed supportively |
NoteThe vector decides the epidemiology, not the virology. Aedes aegypti breeds in clean standing water in urban containers and bites by day, so control is source reduction, larvicide and daytime personal protection. Culex tritaeniorhynchus breeds in rice paddies and bites at dusk, so control is outdoor spraying and bedtime nets. An arbovirus disease cannot be planned for on the basis of its agent alone — the vector's behaviour determines the season and the place.
Picornaviridae and the polio programme
Picornaviruses are small, naked, positive-sense RNA viruses with an icosahedral capsid. Because they are naked, they are stable, they resist gastric acid, and they travel by the faecal–oral route — which is the whole reason poliovirus spreads so effectively before anyone is paralysed.
| Virus | Disease | Notes |
|---|---|---|
| Poliovirus types 1, 2 and 3 | Poliomyelitis: abortive illness, aseptic meningitis, and flaccid paralysis from anterior horn destruction | Type 2 was declared eradicated in 2015 and type 3 in 2019, leaving type 1 as the only circulating wild virus |
| Coxsackie A and B | Hand, foot and mouth disease; herpangina; acute haemorrhagic conjunctivitis; and myocarditis in neonatal infection | Type A16 is the usual cause of hand, foot and mouth disease; type B is the classic cause of viral myocarditis |
| Echovirus | Aseptic meningitis, febrile exanthem, and gastroenteritis | A common cause of summer meningitis |
| Enterovirus 71 | Severe hand, foot and mouth disease with neurological complications | The cause of large outbreaks in Asia |
| Hepatitis A (a picornavirus) | Enterically transmitted hepatitis, most severe in adults | Prevented by a killed vaccine; the presence of anti-HAV IgM indicates recent infection |
The two polio vaccines illustrate every vaccine principle at once. The oral (Sabin) vaccine is live attenuated, cheap, given by mouth, induces intestinal IgA that stops wild-virus spread, and is the reason eradication was achievable — but it can revert and cause vaccine-associated paralytic poliomyelitis, and it cannot be given in immunodeficiency. The injectable (Salk) vaccine is killed, induces serum IgG that prevents paralysis, cannot cause disease, and does not stop intestinal transmission, so it suppresses paralysis but not circulation.
NoteSurveillance for poliomyelitis rests on a single sign: acute flaccid paralysis in a child under 15, reported within 14 days of onset, with two stool samples collected 24–48 hours apart within 14 days of onset. A case of flaccid paralysis with a confirmed wild or vaccine-derived poliovirus confirms circulation; the absence of confirmed cases is the basis on which a region is certified polio-free.
Retroviridae and HIV
| Stage of the HIV cycle | Enzyme or structure involved | Drug class that blocks it |
|---|---|---|
| Attachment and entry | gp120 binds CD4 and then CCR5 or CXCR4; gp41 mediates fusion | CCR5 antagonist maraviroc; fusion inhibitor enfuvirtide; broadly neutralising monoclonal antibodies |
| Reverse transcription | Reverse transcriptase, an error-prone enzyme with no proof-reading | Nucleoside reverse transcriptase inhibitors (zidovudine, tenofovir) and non-nucleoside inhibitors (efavirenz, rilpivirine) |
| Integration | Integrase inserts the viral DNA into host chromosome | Integrase strand transfer inhibitors (dolutegravir, bictegravir) — the backbone of modern regimens |
| Transcription and translation | Host polymerase and ribosome, and the Tat and Rev regulatory proteins | No directly exploited step — the machinery is too similar to the host's own |
| Proteolytic maturation | Viral protease cleaves the gag-pol polyprotein | Protease inhibitors (atazanavir, darunavir) |
| Assembly and budding | Gag assembly at the cell membrane; gp41 fusion of the envelope | Maturation inhibitors remain investigational |
The error-prone reverse transcriptase is why HIV generates resistant mutants continuously and why monotherapy fails. A regimen of two nucleoside reverse transcriptase inhibitors plus an integrase inhibitor therefore attacks three steps at once, so the probability of a single genome simultaneously acquiring mutations to all three is negligible. The same error rate is why HIV exists as a quasispecies — a swarm of related variants within one patient — and why the treatment of a resistant virus requires genotypic testing before a regimen is changed.
Watch outLaboratory monitoring in HIV rests on two numbers. The CD4 count reflects the level of immune damage and predicts which opportunistic infections will appear: Pneumocystis below 200, toxoplasmosis and cryptococcosis below 100, cytomegalovirus retinitis and disseminated Mycobacterium avium below 50. The plasma viral load reflects the amount of virus and the success or failure of therapy, with an undetectable viral load meaning both that the regimen works and that the patient cannot transmit sexually.
HTLV-1 is the second major human retrovirus. It causes adult T-cell leukaemia/lymphoma, with hypercalcaemia and flower-shaped lymphocytes on blood film, and HTLV-1-associated myelopathy (tropical spastic paraparesis) in endemic areas of southern Japan, the Caribbean, West Africa and South America. Unlike HIV, it is weakly transmissible and there is no treatment that clears it — so management is surveillance of the leukaemia and counselling regarding sexual and needle transmission.
Other RNA viruses of daily clinical importance
| Virus and family | Transmission | Disease | Distinguishing feature |
|---|---|---|---|
| Norovirus (Caliciviridae) | Faecal–oral, aerosolised vomitus, contaminated surfaces | Acute gastroenteritis with vomiting, explosive diarrhoea and cramping | A naked virus that survives chlorine and drying, so it causes cruise-ship and ward outbreaks; no vaccine |
| Rotavirus (Reoviridae) | Faecal–oral | Severe infantile gastroenteritis with dehydration | A segmented double-stranded RNA virus, now largely controlled by the oral live vaccine; before vaccination it was the leading infectious cause of infant death |
| SARS-CoV-2 and other coronaviruses | Respiratory droplet and aerosol | COVID-19: asymptomatic infection, pneumonia, multisystem inflammatory syndrome, and long COVID | A positive-sense RNA virus with the largest RNA genome, proof-reading machinery, and a spike protein whose antigenic drift drives variant waves |
| Hepatitis C (Flaviviridae) | Blood-borne, including unsafe injection and transfusion | Chronic hepatitis in most who are infected, cirrhosis and hepatocellular carcinoma | Prevailing cure with 12 weeks of a direct-acting antiviral regimen in more than 95 per cent; no vaccine yet |
| Rabies virus (Rhabdoviridae) | Bite of an infected mammal | Furious rabies with spasms on attempting to drink and hydrophobic spasms, then paralysis and death | A bullet-shaped negative-sense RNA virus with Negri bodies in hippocampal neurons; 100 per cent fatal once symptomatic, and prevented only by immediate post-exposure vaccination and immunoglobulin |
| Ebola and Marburg (Filoviridae) | Direct contact with body fluids of an infected patient | Viral haemorrhagic fever with a high mortality | Disrupts the clotting cascade and the immune response itself; a recombinant vaccine is now in use for outbreak control |
| Rubella virus (Togaviridae) | Respiratory droplet | Rubella and congenital rubella syndrome | A mild exanthem of no consequence to the patient, but a teratogen to the fetus in the first trimester |
NoteRabies is the clearest example in the whole of microbiology of a window that closes. Once the virus reaches the central nervous system there is no effective treatment and mortality is essentially 100 per cent. Before that, thorough wound washing, rabies immunoglobulin infiltrated around the wound where feasible, and a series of vaccine doses are highly effective. 'Rabies is the only infection that is treated after it is clinically inevitable' is the paradox that makes the window worth memorising.
Common mistakes
Watch outConfusing influenza's drift with its shift. Drift is gradual point mutation, causing seasonal epidemics and requiring a vaccine reformulation each year. Shift is abrupt reassortment of the eight segments in a co-infected cell, causing a pandemic and an entirely new H subtype to which nobody is immune.
Watch outCalling dengue vaccine-inducible disease the same as dengue in a non-immune host. Dengue haemorrhagic fever and shock are typically diseases of secondary infection by a different serotype, because non-neutralising antibody from the first infection enhances entry of the second into macrophages — antibody-dependent enhancement. This is why the dengue vaccine is restricted to seropositive recipients in most schedules.
Watch outAssuming a positive IgM means active infection in every arbovirus. Flaviviral IgM tests cross-react extensively between dengue, Zika, West Nile and Japanese encephalitis, so a positive IgM from one arbitrarily selected virus must be confirmed by neutralisation or by nucleic acid detection before it is used to name the virus.
Check your understanding
Why does a child with hand, foot and mouth disease spread enterovirus 71 in the classroom before anyone falls ill, and why is quarantine after symptoms appear ineffective?
A patient on antiretroviral therapy has a persistently detectable viral load despite good adherence. What is the most likely mechanism and the next step?
Why is dengue in a second, different serotype more dangerous than a first infection?
Multiple choice
Which statement about influenza is correct?
A vaccinated, unvaccinated sibling and an unvaccinated child in the same house are exposed to measles, and the vaccinated child does not become ill. Which vaccine property explains the household pattern?
A liver transplant recipient on antiretroviral therapy has a rising cytomegalovirus viral load, and the regimen contains only integrase inhibitors. Why is the rising load most likely to be a resistance problem rather than a break in the viral replication cycle?
Summary and next
The RNA viruses are the most variable of human pathogens, because their polymerases have no proof-reading: influenza develops antigenic drift by mutation and antigenic shift by reassortment of its eight segments; arboviruses and flaviviruses spread by specific vectors whose behaviour dictates their season and their place; enteroviruses survive acid and travel by the faecal oral route, which is what polio eradication exploited and what makes quarantine after symptoms futile; and HIV replicates through a DNA intermediate whose error-prone reverse transcriptase demands multi-class therapy. Other agents — rabies with its absolute fatality after symptoms, norovirus with its detergent resistance, rotavirus with its vaccine, and hepatitis C with its curable direct-acting antivirals — complete the picture of RNA virus disease in daily practice.
Next: medical mycology. You move from viruses to eukaryotes: the dermatophytes, Candida, Cryptococcus, Aspergillus and Mucor, the dimorphic fungi, and the antifungal drug classes that attack the cell-wall chitin and membrane sterols they possess and human cells do not.